Rituximab for Secondary Progressive Multiple Sclerosis: A Case Series

Author： Rommer Paulus S.   Patejdl Robert   Winkelmann Alexander   Benecke Reiner   Zettl Uwe K.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.7, 2011-07, pp. : 607-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Secondary-Progressive Multiple Sclerosis

By Gavin Giovannoni  

CNS Drugs, Vol. 18, Iss. 10, 2004-01 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Paclitaxel therapy is promising in secondary progressive multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Interferon- -1b: A Review of its Use in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By McCormack P.L.   Scott L.J.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 521-546

Adis International

Access to resources Recommend Favorite

Patients with secondary progressive multiple sclerosis (MS) may not benefit from treatment with IV immunoglobulin G (IVIG)

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Rituximab: Progressive multifocal leukoencephalopathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite